Extension of the RENACER Study: 12-Month Efficacy, Safety and Certolizumab PEGol Survival in 501 Rheumatoid Arthritis Patients

Publication date: January 2021Source: Reumatología Clínica (English Edition), Volume 17, Issue 1Author(s): Vicenç Torrente-Segarra, Manuel Fernández Prada, Rosa Expósito, Noemí Patricia Garrido Puñal, Amalia Sánchez-Andrade, José Ramón Lamúa-Riazuelo, Alejandro Olivé, Juan Víctor Tovar, on behalf of RENACER Study Group
Source: Reumatologia Clinica - Category: Rheumatology Source Type: research